Found: 4
Select item for more details and to access through your institution.
PHARMA'S GLOBALIZATION OF CHINA: AstraZeneca Case Study.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
CLR 131 Demonstrates High Rate of Activity in a Phase 1, Dose Escalation Study in Patients with Relapsed or Refractory Multiple Myeloma (RRMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e356, doi. 10.1016/j.clml.2019.09.589
- By:
- Publication type:
- Article
Iopofosine I-131 treatment in late-line patients with relapsed/refractory multiple myeloma post anti-BCMA immunotherapy.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00725-2
- By:
- Publication type:
- Article
Prior injury accelerates subsequent wound closure in a mouse model of regeneration.
- Published in:
- Cell & Tissue Research, 2005, v. 320, n. 3, p. 417, doi. 10.1007/s00441-005-1107-7
- By:
- Publication type:
- Article